Showing results (1-10 of 2,521) with videos related to

Sort By:
Pageof 253
Medical Sciences (Basel, Switzerland)|February 20, 2026
Diagnostic Performance of Angiography-Derived Quantitative Flow Ratio: A Systematic Review and Meta-AnalysisGuo Huang, Pu Ge, He Zhu, et al.
Antibiotics (Basel, Switzerland)|July 29, 2025
Distribution and Determinants of Antibiotic Self-Medication: A Cross-Sectional Study in Chinese ResidentsGuo Huang, Pu Ge, Mengyun Sui, et al.
SSM - Population Health|February 3, 2021
Impact of house price growth on mental health: Evidence from ChinaGuoxu Wei, He Zhu, Sheng Han, et al.
Frontiers in Pharmacology|April 26, 2021
Off-Label Use of Antineoplastic Drugs to Treat Malignancies: Evidence From China Based on a Nationwide Medical Insurance Data AnalysisGuoxu Wei, Min Wu, He Zhu, et al.
International Journal of Health Services : Planning, Administration, Evaluation|March 27, 2013
Can price controls reduce pharmaceutical expenses? A case study of antibacterial expenditures in 12 Chinese hospitals from 1996 to 2005Sheng Han, Huigang Liang, Weiping Su, et al.
Advances in Therapy|March 23, 2019
Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in ChinaHaijing Guan, Yanan Sheng, Wanjie Guo, et al.
Pharmacoeconomics - Open|May 25, 2026
Prediction Error in Quality-Adjusted Life Years in Economic Evaluations of Immune Checkpoint Inhibitors: A Comparison Based on Projected and Observed Updated SurvivalJinyu Chen, Yichen Zhang, Kexin Han, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 11, 2015
Effectiveness of drug treatment strategies to prevent asthma exacerbations and increase symptom-free days in asthmatic children: a network meta-analysisYile Zhao, Sheng Han, Jinxin Shang, et al.
Chinese Medical Journal|June 17, 2014
Exploration of approaches to adjusting brand-name drug prices in Mainland of China: based on comparison and analysis of some brand-name drug prices of Mainland and Taiwan, ChinaGeng Weng, Sheng Han, Run Pu, et al.
Seminars in Oncology|April 20, 2021
Can locally developed me-too drugs aid price negotiation? An example of cancer therapies from ChinaZhenhuan Luo, Bishal Gyawali, Sheng Han, et al.
Pageof 253